Drugs / D091
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07404735 | Feb → May 2026 overdue | benign prostatic hyperplasia | Chong Kun Dang Pharmaceutical | Not yet recruiting | No outcome recorded |
| Phase 1 | NCT06110923 | Nov 2023 → May 2024 | benign prostatic hyperplasia | Chong Kun Dang Pharmaceutical | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | D091 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06110923 ↗ |